Sort
50,496 grants matching “lung cancer”
Project 1 Mouse Models Analysis
$529,826Edgar G. Engleman · Stanford University · U54 · FY2025 · CA
Development of lisinopril for post-exposure mitigation of late effects from a rad
$529,824Meetha M Medhora · Medical College Of Wisconsin · U01 · FY2013 · AI
Local Flavor Policies to Enhance Equity in Tobacco
$529,813Shyanika W Rose · University Of Kentucky · R01 · FY2024 · CA
SOS2 IS A TRACTABLE THERAPEUTIC TARGET TO LIMIT THERAPEUTIC RESISTANCE IN NON-SMALL CELL LUNG CANCER
$529,746The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. · · FY2019 · Defense Health Agency
Corrective Image Reconstruction Methods for ECT
$529,745Benjamin M Tsui · Johns Hopkins University · R01 · FY2010 · EB
Etiologic Studies of Diet and Cancer
$529,739Arthur Schatzkin · Division Of Cancer Epidemiology And Genetics · ZIA · FY2010 · CA
Rapid and affordable magneto-nanosensors for ctDNA-guided lung cancer management
$529,738Shan X. Wang · Stanford University · R01 · FY2024 · CA
TOBACCO AND CANCER RISK--DOSE, METABOLISM AND GENETICS
$529,688Pennsylvania State Univ Hershey Med Ctr · P01 · FY2005 · CA
Clinical Protocol and Data Management/Clinical Trials Office (Core 016)
$529,651Adam M Brufsky · University Of Pittsburgh At Pittsburgh · P30 · FY2017 · CA
Health Effects Of Exposures In Agriculture
$529,644Dale P Sandler · National Institute Of Environmental Health Sciences · ZIA · FY2023 · ES
A Computer Tool for Aiding in Accurate Assessment of Indeterminate Lung Nodules
$529,613Xin Meng · International Intelligent Infor/Solu/Lab · R44 · FY2018 · CA
Therapeutic strategies against EGFR exon 20 mutant lung cancer
$529,607John V. Heymach · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Rexinoid Synergy in Prostate Cancer Apoptosis
$529,569Marcia I. Dawson · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2009 · CA
Screening for inhibitors of NSD3 as a treatment for lung cancer
$529,475Jolanta Grembecka · University Of Michigan At Ann Arbor · R01 · FY2023 · CA
Trans-omics elucidation of genetic architecture underlying cardiovascular and HLBS diseases
$529,473Hua Tang · Stanford University · R01 · FY2020 · HL
Increasing the diagnostic yield of low-risk bronchial biopsy in the evaluation of
$529,451Melissa J Suter · Massachusetts General Hospital · R01 · FY2014 · CA
Cancer Assessments and Reports of End-of-Life Treatment
$529,442Brown University · R01 · FY2003 · CA
Development of Novel Informative Preclinical Animal Models - CAPR Infrastructure
$529,416Shyam Sharan · Division Of Basic Sciences - Nci · ZIG · FY2018 · CA
New mouse model of cisplatin-induced AKI and development of prevention therapy
$529,333Jianjun Zhao · Cleveland Clinic Lerner Com-Cwru · R01 · FY2023 · CA
Integration of Actin Dynamics and Adhesion in Cell Migration
$529,301Clare Michal Waterman · National Heart, Lung, And Blood Institute · ZIA · FY2016 · HL
Molecular mechanisms of tumor-initiated premetastatic niche formation in lung str
$529,299Vivek Mittal · Weill Medical Coll Of Cornell Univ · R01 · FY2010 · CA
Fractionated photoimmunotherapy to harness low-dose immunostimulation in ovarian cancer
$529,280Bryan Quilty Spring · Northeastern University · U01 · FY2023 · CA
Improving Breast Cancer Surgery Quality through a Collaborative Surgery Database
$529,250Laurence Edward McCahill · Van Andel Research Institute · RC1 · FY2010 · CA
Molecular Landscape-based Innovative Therapies for Anaplastic Thyroid Carcinoma
$529,155Antonio Di Cristofano · Sloan-Kettering Inst Can Research · P50 · FY2015 · CA
Nitric Oxide as a Modifier of Oxidative Stress
$529,061David Wink · Division Of Clinical Sciences - Nci · ZIA · FY2021 · CA